Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1062533510 | 10625335 | 10 | F | 2000 | 20160711 | 20141204 | 20160725 | EXP | US-JNJFOC-20141114774 | JANSSEN | 0.00 | C | M | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1062533510 | 10625335 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | Y | U | 0 | TABLETS | ||||||||
| 1062533510 | 10625335 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | Y | U | 0 | TABLETS | ||||||||
| 1062533510 | 10625335 | 3 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | Y | U | 0 | TABLETS | ||||||||
| 1062533510 | 10625335 | 4 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | Y | U | 20272 | TABLETS | ||||||||
| 1062533510 | 10625335 | 5 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | U | U | 20272 | UNSPECIFIED | ||||||||
| 1062533510 | 10625335 | 6 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 1062533510 | 10625335 | 7 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 1062533510 | 10625335 | 8 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 1062533510 | 10625335 | 9 | SS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 1062533510 | 10625335 | 10 | SS | LITHIUM. | LITHIUM | 1 | Oral | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1062533510 | 10625335 | 1 | Abnormal behaviour |
| 1062533510 | 10625335 | 2 | Depression |
| 1062533510 | 10625335 | 3 | Attention deficit/hyperactivity disorder |
| 1062533510 | 10625335 | 4 | Bipolar disorder |
| 1062533510 | 10625335 | 5 | Product used for unknown indication |
| 1062533510 | 10625335 | 6 | Depression |
| 1062533510 | 10625335 | 7 | Bipolar disorder |
| 1062533510 | 10625335 | 8 | Attention deficit/hyperactivity disorder |
| 1062533510 | 10625335 | 9 | Product used for unknown indication |
| 1062533510 | 10625335 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1062533510 | 10625335 | HO |
| 1062533510 | 10625335 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1062533510 | 10625335 | Abnormal weight gain | |
| 1062533510 | 10625335 | Akathisia | |
| 1062533510 | 10625335 | Galactorrhoea | |
| 1062533510 | 10625335 | Gynaecomastia | |
| 1062533510 | 10625335 | Hallucination, auditory | |
| 1062533510 | 10625335 | Hyperprolactinaemia | |
| 1062533510 | 10625335 | Mood swings | |
| 1062533510 | 10625335 | Rabbit syndrome | |
| 1062533510 | 10625335 | Suicidal ideation | |
| 1062533510 | 10625335 | Thinking abnormal | |
| 1062533510 | 10625335 | Treatment noncompliance | |
| 1062533510 | 10625335 | Tremor | |
| 1062533510 | 10625335 | Urinary incontinence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |